1-5 of 5
Carol J. Levy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Diabetes Centers’ Participation in the T1D Exchange Quality Improvement Collaborative Advances Health Equity and Clinical Outcomes

Siham Accacha, Ann Mungmode, Lori Benzoni, Nicole Rioles, Grazia Aleppo, Devin Steenkamp, Carol J. Levy, Zoltan Antal, Jenise C. Wong, Grace Nelson, G. Todd Alonso, Osagie Ebekozien
Journal: Clinical Diabetes
Clin Diabetes 2025;43(1):100–108
https://doi.org/10.2337/cd24-0058
Published: 07 October 2024
View article titled, Diabetes Centers’ Participation in the T1D Exchange Quality Improvement Collaborative Advances Health Equity and Clinical Outcomes
Open the PDF for Diabetes Centers’ Participation in the T1D Exchange Quality Improvement Collaborative Advances Health Equity and Clinical Outcomes in another window
Journal Articles

Insulin Titration Recommendations When Using Glucagon-Like Peptide 1 Receptor Agonist Therapy in Adults With Type 1 Diabetes

Zeb I. Saeed, Halis K. Akturk, Grazia Aleppo, Davida Kruger, Carol J. Levy, Julia K. Mader, Jennifer L. Sherr, Viral N. Shah
Journal: Clinical Diabetes
Clin Diabetes 2025;43(1):131–138
https://doi.org/10.2337/cd24-0067
Published: 20 September 2024
View article titled, Insulin Titration Recommendations When Using Glucagon-Like Peptide 1 Receptor Agonist Therapy in Adults With Type 1 Diabetes
Open the PDF for Insulin Titration Recommendations When Using Glucagon-Like Peptide 1 Receptor Agonist Therapy in Adults With Type 1 Diabetes in another window
Journal Articles

Beneficial Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Use With Control-IQ Technology in Type 2 Diabetes

Roy W. Beck, Carol J. Levy, Yogish C. Kudva, Keta Pandit, Thomas Blevins, Dan Raghinaru, Jordan E. Pinsker
Journal: Clinical Diabetes
Clin Diabetes 2024;42(4):547–549
https://doi.org/10.2337/cd23-0107
Published: 17 April 2024
View article titled, Beneficial Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Use With Control-IQ Technology in Type 2 Diabetes
Open the PDF for Beneficial Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Use With Control-IQ Technology in Type 2 Diabetes in another window
Journal Articles

Beneficial Effects of Control-IQ Automated Insulin Delivery in Basal-Bolus and Basal-Only Insulin Users With Type 2 Diabetes

Carol J. Levy, Dan Raghinaru, Yogish C. Kudva, Keta Pandit, Thomas Blevins, Luis Casaubon, Donna Desjardins, Camilla M. Levister, Grenye O’Malley, Corey Reid, John Lum, Craig Kollman, Roy W. Beck
Journal: Clinical Diabetes
Clin Diabetes 2024;42(1):116–124
https://doi.org/10.2337/cd23-0025
Published: 28 August 2023
View article titled, Beneficial Effects of Control-IQ Automated Insulin Delivery in Basal-Bolus and Basal-Only Insulin Users With Type 2 Diabetes
Open the PDF for Beneficial Effects of Control-IQ Automated Insulin Delivery in Basal-Bolus and Basal-Only Insulin Users With Type 2 Diabetes in another window
Journal Articles

A Novel Algorithm for the Management of Inpatient COVID-19 Glucocorticoid-Induced Hyperglycemia

Alexander B. Karol, Natalia Viera, Selassie J. Ogyaadu, Danielle Brooks, Nirali A. Shah, Anne S. Linker, David W. Lam, Carol J. Levy, Grenye O’Malley
Journal: Clinical Diabetes
Clin Diabetes 2023;41(3):378–385
https://doi.org/10.2337/cd22-0083
Published: 02 March 2023
View article titled, A Novel Algorithm for the Management of Inpatient COVID-19 Glucocorticoid-Induced Hyperglycemia
Open the PDF for A Novel Algorithm for the Management of Inpatient COVID-19 Glucocorticoid-Induced Hyperglycemia in another window